搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
oncnursingnews
4 天
Nurses Can Help ‘Demystify’ Genetic Testing Results
Oncology nurses “play a pivotal role in guiding patients” through the genetic testing process, an expert explained.
oncnursingnews
5 天
Accelerated Approval Sought for RP1-Nivolumab Combo for Pretreated Melanoma
The FDA received a biologics license application for accelerated approval of RP1 plus nivolumab for advanced, pretreated ...
oncnursingnews
9 天
Rapid Taper Plays Role in Suspected Opioid Misuse in Patients With Cancer
Clinicians should consider a rapid taper approach for patients with cancer who exhibit repeated signs of opioid misuse, an ...
oncnursingnews
14 天
FDA Grants Rare Pediatric Designation to Elraglusib for Ewing Sarcoma
The FDA granted elraglusib a rare pediatric disease designation for Ewing sarcoma based on findings from the 1/2 Actuate-1902 ...
oncnursingnews
8 天
FDA Approves Zanidatamab for Pretreated HER2-Positive Biliary Tract Cancer
The FDA granted an accelerated approval to zanidatamab-hrii for previously treated, unresectable or metastatic HER2-positve ...
oncnursingnews
9 天
FDA Fast Tracks ALE.P02 for CLDN1-Poisitive Solid Cancers
The FDA granted a fast track designation to ALE-P02 for patients with CLDN1-positive squamous solid tumors. The FDA granted ...
oncnursingnews
8 天
FDA Accepts New Drug Application to Darolutamide Plus ADP for mHSPC
The FDA accepted a supplemental new drug application to darolutamide plus androgen deprivation therapy for metastatic hormone ...
oncnursingnews
14 天
FDA Approves Revumenib for Relapsed, Refractory Acute Leukemia With a KMT2A Translocation
The FDA has approved revumenib (Revuforj) for the treatment of adult and pediatric patients aged 1 year and older with ...
oncnursingnews
5 天
Breast Cancer
A nurse practitioner discusses how breast cancer treatment can impact sexual health, and how nurses and APPs can guide patients through these effects.
oncnursingnews
17 天
Caregivers, Clinicians Must Be Familiar With CRS Risk After CAR T-Cell Therapy
At a recent Community Case Forum, an expert discussed the risk of cytokine release syndrome after patients undergo CAR T-cell ...
oncnursingnews
19 天
Rick Bulifant
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈